You are here

Equillium to Present at Leerink Partners Global Healthcare Conference

LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce Steel, Equillium’s president and chief business officer, will present at the Leerink Partners 8th Annual Global Healthcare Conference on Thursday, February 28, 2019.
Thursday, February 21, 2019 - 16:07